AGL 37.50 Decreased By ▼ -0.08 (-0.21%)
AIRLINK 222.89 Increased By ▲ 0.46 (0.21%)
BOP 10.82 Decreased By ▼ -0.14 (-1.28%)
CNERGY 7.56 Decreased By ▼ -0.10 (-1.31%)
DCL 9.42 Decreased By ▼ -0.21 (-2.18%)
DFML 40.96 Decreased By ▼ -0.74 (-1.77%)
DGKC 106.76 Decreased By ▼ -3.99 (-3.6%)
FCCL 37.07 Decreased By ▼ -0.99 (-2.6%)
FFL 19.24 Increased By ▲ 0.95 (5.19%)
HASCOL 13.18 Decreased By ▼ -0.19 (-1.42%)
HUBC 132.64 Decreased By ▼ -2.32 (-1.72%)
HUMNL 14.73 Decreased By ▼ -0.86 (-5.52%)
KEL 5.40 Decreased By ▼ -0.16 (-2.88%)
KOSM 7.48 Increased By ▲ 0.07 (0.94%)
MLCF 48.18 Decreased By ▼ -2.15 (-4.27%)
NBP 66.29 Decreased By ▼ -0.18 (-0.27%)
OGDC 223.26 Decreased By ▼ -5.35 (-2.34%)
PAEL 43.50 Increased By ▲ 0.13 (0.3%)
PIBTL 9.07 Decreased By ▼ -0.23 (-2.47%)
PPL 198.24 Decreased By ▼ -4.89 (-2.41%)
PRL 42.24 Decreased By ▼ -0.62 (-1.45%)
PTC 27.39 Increased By ▲ 0.06 (0.22%)
SEARL 110.08 Increased By ▲ 3.06 (2.86%)
TELE 10.52 Increased By ▲ 0.74 (7.57%)
TOMCL 36.62 Decreased By ▼ -0.01 (-0.03%)
TPLP 14.95 Decreased By ▼ -0.28 (-1.84%)
TREET 26.53 Decreased By ▼ -0.26 (-0.97%)
TRG 68.85 Decreased By ▼ -1.30 (-1.85%)
UNITY 34.19 No Change ▼ 0.00 (0%)
WTL 1.79 Increased By ▲ 0.03 (1.7%)
BR100 12,363 Decreased By -32.9 (-0.27%)
BR30 38,218 Decreased By -629.2 (-1.62%)
KSE100 117,120 Increased By 111.6 (0.1%)
KSE30 36,937 Increased By 72.2 (0.2%)

PARIS: More than two billion Covid-19 vaccines have been given across the world, according to an AFP tally Thursday drawn from official sources. The milestone comes six months after the first vaccination campaigns against Covid-19 began.

At least 2,109,696,022 shots have been given in 215 countries and territories, according to the count from an AFP database taken at 0915 GMT. Israel, which has led the race from the start, is still out in front, with nearly six in 10 people there fully vaccinated.

It is followed by Canada (59 percent of the population have had at least one jab), the United Kingdom (58.3 percent), Chile (56.6 percent) and the United States (51 percent).

Six out of 10 of the injections have been administered in the world's three most populous countries - China (704.8 million doses), the US (296.9 million) and India (221 million).

Nearly four out of 10 people in the European Union have had at least one shot, with Germany leading with 43.6 percent, followed by Italy (40 percent) and France and Spain on 39.4 percent.

Only six countries in the world have not yet started vaccinating - North Korea, Haiti, Tanzania, Chad, Burundi an Eritrea. But with vaccination programmes now accelerating globally, China leads the league of countries giving doses the fastest over the last week, injecting 1.37 percent of its population per day.

Bahrain and Uruguay are also covering about one percent a day. Germany is not far off that as the leader of the EU bunch followed by Italy (0.81 percent) and Spain (0.71 percent).

Despite being ravaged by the pandemic, the speed of vaccination in India and Brazil has been much slower, covering only 0.19 of the population in India's case and 0.29 of Brazil's. In fact there is still huge inequality in the spread of vaccines, with only 2.5 doses per 100 people in Africa against 87 per 100 in the US and Canada and 47 in Europe.

The world's poorest countries have given only 0.3 percent of the jabs while the richest got four out of 10 shots even though they have only 16 percent of the global population. Oxford/AstraZeneca is the most widely given vaccine, administered in 170 of the 215 countries where campaigns have begun.

It is followed by Pfizer/BioNTech, which is being used in at least 97 countries; Moderna (at least 46); Sinopharm (45); Sputnik V (40); Johnson & Johnson (29).

The Oxford/AstraZeneca shot is also the mainstay of the Covax vaccine sharing programme for poorer countries, while the Pfizer/BioNTech and Moderna jabs - which are more difficult to store - are the preserve of wealthier countries. Like Russia's Sputnik V, the Chinese vaccines developed by Sinopharm and Sinovac have been used most by emerging or developing nations.

Comments

Comments are closed.